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CASES STUDIES
1. Introduction1
Acute pancreatitis (AP) is very a common critical disease
in clinical due to various reasons cited intestinal trypsin
activation leads to local pancreas tissue inflammation,
also can be associated with other organ function [1]. Mild
acute pancreatitis (MAP) is one of the most common clini-
cal symptoms of acute pancreatitis. About 30% of untreat-
ed MAP could develop to severe acute pancreatitis (SAP)
that is critically ill and the prognosis was not completely
known for the pathogenesis of acute pancreatitis. However,
a number of studies showed that cytokines and inflamma-
tory factors play an important role in the development of
acute pancreatitis [2]. The paper presented reliable diag-
nostic data for early diagnosis, treatment and prognosis of
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acute pancreatitis (AP) in 65 patients with acute pancreati-
tis (TNF-α).
2. Materials and methods
2.1. Clinical data
From January 2013 to January 2015, a total of 65 patients
of acute pancreatitis receiving treatment, and there were 40
males and 25 females. The mean age was 45.5 ± 13.5 years
old (range: 23‒67 years). The admission criteria should be
in accordance with the following: The patient were consis-
tent with the diagnosis and treatment of acute pancreati-
tis. Guide to the exclusion of other diseases of the patients
with acute abdomen. The patients were not drug therapy
and anti-infection drugs allergy. Etiology: 35 cases of gall-
stone disease, 28 cases of severe drinking, 2 cases of high
blood lipids. According to the standard of acute pancreatitis:
30 cases of mild acute pancreatitis (MAP), 35 cases of severe
acute pancreatitis (SAP). As a control, 60 healthy subjects
in our hospital were selected as the control group, and there
were 38 males and 23 females with the mean age of 43.5 ±
14.5 years (aged 26‒68 years). Age and gender were not sig-
nificantly different between control group and case group.
2.2. Treatment method







ABSTRACT  Objective: The aimed of this study is to investigate the changes in serum 
levels of tumor necrosis factor (TNF-α) in the patients with acute pancreatitis treated 
with octreotide and its clinical significance. Method: Total of 65 patients of acute pan-
creatitis were selected as a case study, in which 30 patients with mild acute pancreatitis 
(MAP) and 35 severe acute pancreatitis (SAP) patients were treated with octreotide. 60 
healthy subjects as control group and 65 case group was subjected to performed double 
antibody sandwich enzyme-linked immunosorbent assay (ELISA) to detect the serum 
levels of TNF-α. Results: The serum TNF-α level in the case group was (12.67 ± 3.45) 
pg/ml and the control group was (1.56 ± 0.57) pg/mL. Case group was significantly 
higher than control group (p < 0.05). Serum level of acute pancreatitis (AP) before 
treatment was (8.96 ± 2.12) pg/mL. After treatment, SAP group was (17.34 + 4.56) pg/
mL, MAP group was significantly lower than SAP group, and the difference was statis-
tically significant (p < 0.05). Conclusion: The serum levels of TNF-α in patient with 
acute pancreatitis were significantly higher than those of normal healthy people, and 
their serum level was closely related to the severity of illness.
Changes of Serum TNF-α in Acute Pancreatitis 
Patients and Its Clinical Significance
Wenrui Yang*
Department of General Surgery, The People’s Hospital of Pinglu District, Shuozhou, Shanxi 036800, China
2   |   Volume 5 Issue 4   |   December   2016
given Beijing Connaught Pharmaceutical Co., Ltd. the 
production of acetate octreotide 0.6 mg intravenous infu-
sion in the treatment, the patients with abdominal pain 
and abdominal distension wait for a symptom to be allevi-
ated, reduced to 0.3. Co-treatment such as fasting, water 
deprivation, anti-acid and anti-inflammatory symptomatic 
support treatment, parenteral nutrition support treatment, 
maintain water and electrolyte balance, to have occurred 
in patients with liver damage given liver and reducing en-
zyme treatment for two weeks.
2.3. Detection method
5 mL of peripheral blood was extracted from acute pancre-
atitis patients after 24 h admission and the control group 
blood was withdrawn during their physical examination 
day with the similar volume. The blood sample was run 
under centrifugation at 4000 rpm for 10 minutes for frac-
tionation. The separated serum was stored in the refrigera-
tor at -80 ºc. Double antibody sandwich ELISA method 
was employed to detect the serum TNF-α in the partici-
pants.
2.4. Observation index
To observe the serum TNF-α level of the patients in the 
treatment group and the control group before treatment. 
To observe the serum TNF-α level before and after treat-
ment in the patients with SAP.
2.5. Statistical analysis
Statistical Analysis was performed by SPSS version 15.0 
software. Data were measured by p < 0.05 + s (x), the count 
data were analyzed by x2 test, and the data were statistically 
analyzed by t test.
3. Results
3.1. Comparison of serum TNF-α level in untreated
patients and the control group
The level of serum TNF-α in patients was (12.67 + 3.45)
pg/ml, and the control group was (1.56 + 0.57) pg/mL and
the case group was significantly higher than that of the
control group. There were significant differences between
the two groups (p < 0.05). (Table 1)
Table 1. Comparison of serum TNF-α level in patients with 
acute pancreatitis before treatment and control group.
Group Cases Serum TNF-α (pg/mL)
Case group 65 12.67 ± 3.45
Control group 60 1.56 ± 0.57
t - 145.39
p - < 0.05
3.2. Comparison of serum TNF-α levels before and af-
ter treatment in the case group
Before treatment, the level of serum TNF-α in the case 
group was (2.12 + 3.45) pg/mL, after treatment, the dif-
ference was statistically significant, that is, p < 0.05, before 
and after treatment, the difference was statistically signifi-
cant. (Table 2)
Table 2. Comparison of serum TNF-α level before and after 
treatment in the case group.
Group Cases Serum TNF-α ( pg/mL )
Before treatment 65 12.67 ± 3.45
After treatment 65 5.78 ± 2.12
t - 24.24
p - < 0.05
4. Discussion
Acute pancreatitis is a common clinical emergency. Its
pathogenicity due to intrapancreatic trypsin activation
from variety of disease which caused by pancreatic trache-
al swelling, hemorrhage and necrosis. The primary clini-
cal symptoms were abdominal pain, fever and nausea and
vomiting. Clinical diagnosis could be performed by blood
test. The specific symptoms include the following five
points: first, in the extreme fatigue or binge eating after the
attack, the main symptoms of the upper left abdomen pain,
mild pain and gradually increased, classis signs of shock
may appear in more severely ill patients. Second, frequent
nausea and vomiting symptoms and the symptoms will
change as an increase in the severity of the disease. Fourth,
fever. Since this disease belongs to the inflammatory dis-
ease, it will induce temperature rise. Mild pancreatitis body
temperature will be at 39 ºc or lesser and able to reduce fe-
ver. The body temperature could reach to 40 ºc and it could
be the presence of sepsis. Fifth, necrotic pancreatitis and
inflammatory fluid exudation could reach the abdominal
subcutaneous tissue, the dissolution of subcutaneous fat
causing blood vessels rupture and local skin appear blue
purple. Purple colour may appear in the lower abdomen
and the navel. In complications, it may lead to systemic
complications, including renal failure, acute respiratory
failure, sepsis, high blood glucose or heart failure and
other symptoms. The performance of acute pancreatitis
in patients with mild edema and the disease can be cured
by the body itself. Some patients showed pancreatic ne-
crosis and then lead to infection or even shock that lead
to death. The factors causing pancreatitis in the current
academic community has not been determined, generally
considered the following seven factors: first, mechanical
obstruction factor. Certain patients may suffer from bile
reflux caused by roundworm, stones, etc., into pancre-
atic acinar and even lead to pancreatic gland rupture, so
that the trypsin pancreatic inflammation. Second, alcohol
consumption factors. Long term alcohol consumption
of people prone to pancreatitis, large amounts of alcohol
will promote the secretion of pancreatin and the trypsin
will cause pancreatic inflammation. Moreover, presence
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of high protein food and alcohol could easily lead to 
pancreatitis. Third, vascular factors. Stenosis or obstruc-
tion of the pancreatic periphery may result in ischemic 
necrosis of the pancreas. Fourth, trauma factor. Pancre-
atic trauma does not have suitable treatment, will lead to 
the rupture of the pancreatic duct, pancreatic fluid spills 
leading to inflammation. Fifth, bacterial infection. The 
presence of bacteria or viruses in the blood and the blood 
flow through the pancreatic tissue could cause pancrea-
titis. Sixth. Other disease factors. High cholesterol may 
cause pancreatitis. Seventh, other factors. Such as genetic 
and drug allergies, etc. 
Mild pancreatitis patients only show pancreatic edema 
and self-limited disease associated with little or no distant 
organ dysfunction, however it could develop into SAP 
[3]. Clinical practice showed that SAP disease has rapid 
changes and the mortality rate could be as high as 40%. At 
present, it is considered that the occurrence of acute pan-
creatitis is related to many factors. Pathogenic factors; pan-
creatic enzymes are activated, pancreatic juice secretion 
increased, pancreatic duct pressure increased, large gland 
cell rupture, pancreatin is abnormal activation leading to 
the leakage of large amount of trypsin that results in pan-
creatic auto-digestion. In addition, cytokines activated and 
various inflammatory mediators in the development of 
acute pancreatitis. In the early stage of acute pancreatitis, 
pancreatic enzymes and cytokines may enter the peritone-
al cavity. It can be absorbed into the blood through many 
channels, so that the mononuclear macrophages activated 
and release a variety of cytokines and inflammatory me-
diators, and causing multi organ failure leading to a series 
of clinical symptoms and signs. In the present study, the 
serum level of patients in the case group was significantly 
higher than that in the control group before treatment, the 
difference was statistically significant, that is, p < 0.05.
In summary, TNF-α levels were elevated in the serum of 
patients with acute pancreatitis, and were closely correlated 
with the severity of the disease by octreotide treatment can 
reduce the serum TNF-α levels. Therefore, serum TNF-α 
levels can be as acute pancreatitis patient assessment and 
evaluation of curative effect, an important indicator of the 
prognosis evaluation [4] and octreotide in the treatment of 
patients with acute pancreatitis, remarkable curative effect, 
it is worth of clinical application.
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